04-02-2026 17:38 via drugs.com

High-Value Program Involves Less Frequent Screens After HPV Vaccination

WEDNESDAY, Feb. 4, 2026-- For women who are vaccinated against human papillomavirus (HPV) by age 30 years, a high-value screening program likely involves less frequent screening, according to a study published online Feb. 3 in the Annals of...

FDA Approves Quadruplet Regimen for Adults With Newly Diagnosed Multiple Myeloma

Consensus Statement Addresses Triaging of Adults With UTI Concerns

Guideline Updated for Early Management of Acute Ischemic Stroke

Gap Exists Between Expectations, Experience in Perimenopause

Maternal Anemia, Erythrocytosis Linked to Neonatal Morbidity and Mortality

Psychotherapy Can Improve Grief Disorder for Bereaved Persons

Sex Hormones Linked to Cardiovascular Events in Men With Type 2 Diabetes

Prevalence of Obesity in U.S. Set to Reach 46.9 Percent by 2035

Dad’s Early Bond May Affect a Child’s Health Years Later, Study Finds

Two Measles Cases Found at Texas Immigrant Detention Center

Slashed Foreign Aid May Cost 9.4 Million Lives by 2030, Study Says

RFK Jr. Expands Faith-Based Addiction Care as Drug Use and Homelessness Rise

Ultra-Processed Foods Might Shorten The Lives Of Cancer Survivors

Pink Noise Might Interfere With Healthy Sleep, Trial Finds

Desktop versie

High-Value Program Involves Less Frequent Screens After HPV Vaccination

Pharmaceutical news